Intradetrusor onabotulinumtoxinA injection: how I do it.
Publication/Presentation Date
2-1-2013
Abstract
Overactive bladder is a highly prevalent condition that may have significant impact on quality of life. This condition may be idiopathic or may have a neurogenic etiology. Antimuscarinics have long been the preferred agents for the treatment of this condition. OnabotulinumtoxinA, an injectible agent that prevents presynaptic release of acetylcholine at the neuromuscular junction, has emerged as an important option in the management of patients with urinary incontinence caused by refractory detrusor overactivity. This manuscript describes our technique for performing utilizing this therapy, describes key equipment needed and provides technical tips for avoiding common pitfalls.
Volume
20
Issue
1
First Page
6649
Last Page
6655
ISSN
1488-5581
Published In/Presented At
Shenot, P. J., & Mark, J. R. (2013). Intradetrusor onabotulinumtoxinA injection: how I do it. The Canadian journal of urology, 20(1), 6649–6655.
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
23433140
Department(s)
Administration and Leadership
Document Type
Article